Literature DB >> 27657187

The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.

Christina S Faherty1,2, Tao Wu1, Carolyn R Morris1,3, Christen L Grassel1, David A Rasko3, Jill M Harper4, Terez Shea-Donohue4, Alessio Fasano2, Eileen M Barry1.   

Abstract

Shigella flexneri is a Gram-negative pathogen that invades the colonic epithelium and causes millions of cases of watery diarrhea or bacillary dysentery predominately in children under the age of 5 years in developing countries. The effector Shigella enterotoxin 2 (ShET2), or OspD3, is encoded by the sen or ospD3 gene on the virulence plasmid. Previous literature has suggested that ospD3 is in an operon downstream of the ospC1 gene, and expression of both genes is controlled by a promoter upstream of ospC1. Since the intergenic region is 328 bases in length and contains several putative promoter regions, we hypothesized the genes are independently expressed. Here we provide data that ospD3 and ospC1 are not co-transcribed and that OspC1 is not required for OspD3/ShET2 function. Most importantly, we identified strong promoter activity in the intergenic region and demonstrate that OspD3/ShET2 can be expressed and secreted independently of OspC1. This work increases our understanding of the synthesis of a unique virulence factor and provides further insights into Shigella pathogenesis.

Entities:  

Keywords:  OspC1; OspD3; ShET2; Shigella flexneri; enterotoxin; type-III secretion system

Mesh:

Substances:

Year:  2016        PMID: 27657187      PMCID: PMC5103656          DOI: 10.1080/19490976.2016.1239682

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  47 in total

1.  Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen.

Authors:  Sacha Lucchini; Hong Liu; Qi Jin; Jay C D Hinton; Jun Yu
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  The Pseudomonas syringae HrpJ protein controls the secretion of type III translocator proteins and has a virulence role inside plant cells.

Authors:  Emerson Crabill; Andrew Karpisek; James R Alfano
Journal:  Mol Microbiol       Date:  2012-06-05       Impact factor: 3.501

3.  Transcriptional adaptation of Shigella flexneri during adherence to epithelial cells.

Authors:  Zhiwei Ni; Lingyan Jiang; Lu Feng; Lei Wang; Bin Liu
Journal:  J Basic Microbiol       Date:  2014-10-07       Impact factor: 2.281

4.  Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri.

Authors:  Maria Mavris; Philippe J Sansonetti; Claude Parsot
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

5.  Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid.

Authors:  A T Maurelli; B Blackmon; R Curtiss
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Characterization of intracellular growth regulator icgR by utilizing transcriptomics to identify mediators of pathogenesis in Shigella flexneri.

Authors:  Carolyn R Morris; Christen L Grassel; Julia C Redman; Jason W Sahl; Eileen M Barry; David A Rasko
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

7.  Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media.

Authors:  Karen L Kotloff; Jakub K Simon; Marcela F Pasetti; Marcelo B Sztein; Stacey L Wooden; Sofie Livio; James P Nataro; William C Blackwelder; Eileen M Barry; Wendy Picking; Myron M Levine
Journal:  Hum Vaccin       Date:  2007-07-15

8.  Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo.

Authors:  Christina S Faherty; Christina Faherty; Jill M Harper; Terez Shea-Donohue; Eileen M Barry; James B Kaper; Alessio Fasano; James P Nataro
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

9.  Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection.

Authors:  Mo-fei Li; Bao-cun Zhang; Jun Li; Li Sun
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

10.  Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation.

Authors:  A Dorothea Roehrich; Enora Guillossou; Ariel J Blocker; Isabel Martinez-Argudo
Journal:  Mol Microbiol       Date:  2013-01-11       Impact factor: 3.501

View more
  7 in total

1.  Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts.

Authors:  Kourtney P Nickerson; Rachael B Chanin; Jeticia R Sistrunk; David A Rasko; Peter J Fink; Eileen M Barry; James P Nataro; Christina S Faherty
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

2.  Antibiofilm Activity of Lactobacillus plantarum 12 Exopolysaccharides against Shigella flexneri.

Authors:  Yinglong Song; Mengying Sun; Lu Feng; Xue Liang; Xing Song; Guangqing Mu; Yanfeng Tuo; Shujuan Jiang; Fang Qian
Journal:  Appl Environ Microbiol       Date:  2020-07-20       Impact factor: 4.792

3.  Bacteriophage Therapy Testing Against Shigella flexneri in a Novel Human Intestinal Organoid-Derived Infection Model.

Authors:  Alejandro Llanos-Chea; Robert J Citorik; Kourtney P Nickerson; Laura Ingano; Gloria Serena; Stefania Senger; Timothy K Lu; Alessio Fasano; Christina S Faherty
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-04       Impact factor: 2.839

Review 4.  How Do the Virulence Factors of Shigella Work Together to Cause Disease?

Authors:  Emily Mattock; Ariel J Blocker
Journal:  Front Cell Infect Microbiol       Date:  2017-03-24       Impact factor: 5.293

5.  Shigella flexneri Adherence Factor Expression in In Vivo-Like Conditions.

Authors:  Rachael B Chanin; Kourtney P Nickerson; Alejandro Llanos-Chea; Jeticia R Sistrunk; David A Rasko; Deepak Kumar Vijaya Kumar; John de la Parra; Jared R Auclair; Jessica Ding; Kelvin Li; Snaha Krishna Dogiparthi; Benjamin J D Kusber; Christina S Faherty
Journal:  mSphere       Date:  2019-11-13       Impact factor: 4.389

6.  A unique bacterial tactic to circumvent the cell death crosstalk induced by blockade of caspase-8.

Authors:  Hiroshi Ashida; Chihiro Sasakawa; Toshihiko Suzuki
Journal:  EMBO J       Date:  2020-07-13       Impact factor: 11.598

7.  A Versatile Human Intestinal Organoid-Derived Epithelial Monolayer Model for the Study of Enteric Pathogens.

Authors:  Stefania Senger; Christina S Faherty; Kourtney P Nickerson; Alejandro Llanos-Chea; Laura Ingano; Gloria Serena; Alba Miranda-Ribera; Meryl Perlman; Rosiane Lima; Marcelo B Sztein; Alessio Fasano
Journal:  Microbiol Spectr       Date:  2021-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.